Ocera Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OCRX and buy or sell other stocks, ETFs, and their options commission-free!

About OCRX

Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. 

CEO
Kathleen A. Schaefer
CEOKathleen A. Schaefer
Employees
Employees
Headquarters
Hazelwood, Missouri
HeadquartersHazelwood, Missouri
Founded
2004
Founded2004
Employees
Employees

OCRX Key Statistics

Market cap
47.46M
Market cap47.46M
Price-Earnings ratio
-1.85
Price-Earnings ratio-1.85
Dividend yield
Dividend yield
Average volume
321.18K
Average volume321.18K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.95
52 Week high$2.95
52 Week low
$0.52
52 Week low$0.52

Stock Snapshot

The current Ocera Therapeutics(OCRX) stock price is $1.79, with a market capitalization of 47.46M. The stock trades at a price-to-earnings (P/E) ratio of -1.85.

During the trading day, Ocera Therapeutics(OCRX) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 321.18K.

Over the past 52 weeks, Ocera Therapeutics(OCRX) stock has traded between a high of $2.95 and a low of $0.52.

Over the past 52 weeks, Ocera Therapeutics(OCRX) stock has traded between a high of $2.95 and a low of $0.52.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.